While our efforts to stop COVID-19 remain critical, they haven’t slowed our quest to cure cancer. Hear from scientists who are finding vulnerabilities in solid tumors — including breast, lung, and stomach cancers — to design better treatments and cures. We’ll also share up-to-the-minute insights about COVID and answer your questions.
Fred Hutch is world-renowned for pioneering bone marrow transplantation, T-cell therapies, and other strategies that use the power of the immune system to treat and cure blood cancers, like leukemia and lymphoma. We’re using our understanding of cancer and immunity to develop new solid tumor therapies that can be tailored to each patient’s biology and the unique characteristics of their cancer. President and Director Dr. Tom Lynch, a lung cancer physician, will talk with scientists who are leading the way.
Dr. Thomas J. Lynch Jr., Fred Hutch president and director, is a lung cancer physician and scientist known around the world for his pioneering role in precision medicine. He joined the Hutch just weeks before the pandemic began and has guided the organization’s response with urgency, compassion, and a commitment to sparking scientific solutions — all while advancing the cancer research at the heart of its mission. He holds the Raisbeck Endowed Chair.
Dr. Nancy Davidson, who leads Fred Hutch’s Clinical Research Division and Seattle Cancer Care Alliance, builds bridges across cancer research and treatment programs. She is a breast cancer physician and researcher, known for teasing out the role of hormones in breast cancer growth. Dr. Davidson holds the Raisbeck Endowed Chair for Collaborative Research and is past president of both the American Association for Cancer Research and the American Society of Clinical Oncology.
Dr. McGarry Houghton is developing new methods to detect and treat lung cancer, the leading cause of cancer deaths worldwide. He leads lung cancer research at the Hutch and oversees a $13 million, five-year National Cancer Institute grant that brings together experts to fast-track breakthroughs from the lab to the clinic. In his own research, Dr. Houghton explores how cancer co-opts immune cells for its own survival. His discoveries are paving the way to potential new therapies.
Dr. Nina Salama is unraveling the basic biology of Helicobacter pylori, a bacterium that is a key risk factor for stomach cancer. Her team studies every aspect of the bug, from how its distinct shape helps it survive to how it interacts with other bacteria in our bodies. Their fundamental findings are helping explain why some people with H. pylori develop stomach cancer and pointing to new strategies to prevent the disease. Dr. Salama holds the Dr. Penny E. Peterson Memorial Chair for Lymphoma Research.
Dr. Joshua Schiffer is an infectious disease physician who uses computer modeling to study COVID-19 transmission, including how variants affect the virus’s spread. His research has reinforced the importance of widespread masking and testing, and he is a strong advocate for developing treatments that interrupt COVID-19 early in the course of infection. Dr. Schiffer is one of many researchers leading clinical trials at Fred Hutch's COVID-19 Clinical Research Center.